Because infection-elicited anti-spike antibodies also decline rapidly after recovery from SARS-CoV-2 infection, it is likely that this reflects an intrinsic property of the spike protein rather than the mode of vaccine delivery. This evidence concerns the gene CHMP5 and infection.